The Effect of NUDT15, TPMT, APEX1, and ITPA Genetic Variations on Mercaptopurine Treatment of Pediatric Acute Lymphoblastic Leukemia. The gene discussed is APEX1; the disease is acute lymphoblastic leukemia.